Abstract
The optimal hormonal therapy for transsexual patients is not known. The physical and hormonal characteristics of 38 noncastrate male-to-female transsexuals and 14 noncastrate female-to-male transsexuals have been measured before and/or during therapy with various forms and dosages of hormonal therapy. All patients were hormonally and physically normal prior to therapy. Ethinyl estradiol was superior to conjugated estrogen in suppression of testosterone and gonadotropins but equal in effecting breast growth. The changes in physical and hormonal characteristics were the same for 0.1 mg/d and 0.5 mg/d of ethinyl estradiol. The female-to-male transsexuals were well managed with a dose of intramuscular testosterone cypionate of 400 mg/month, usually given 200 mg every two weeks. The maximal clitoral length reached was usually 4 cm. Higher doses of testosterone did not further increase clitoral length or suppression of gonadotropins; lower doses did not suppress the gonadotropins. Based on the information found in this study, we recommend 0.1 mg/d of ethinyl estradiol for the noncastrate male-to-female transsexual and 200 mg of intramuscular testosterone cypionate every two weeks for the noncastrate female-to-male transsexual.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akesode, F. A., Meyer, W. J., and Migeon, C. J. (1977). Male pseudohermaphroditism with gynaecomastia due to testicular 17-ketosteroid reductase deficiency.Clin. Endocrinol. 7: 443–452.
Benjamin, H. (1966).The Transsexual Phenomenon The Julian Press, New York, pp. 92–99, 154–155.
Camacho, A. M., Williams, D. L., and Montalvo, J. M. (1972). Alterations of testicular histology and chromosomes in patients with constitutional sexual precocity treated with medroxyprogesterone acetate.J. Clin. Endocrinol. Metab. 34: 279–286.
Cooke, I. D. (1978).The Role of Estrogen/Progestogen in the Management of the Menopause University Park Press, Baltimore.
Davey, D. A. (1976). The menopause and postmenopause. In Dewhurst, C. J. (ed.),Integrated Obstetrics and Gynaecology for Postgraduates Blackwell Scientific Publications, Oxford, pp. 635–649.
de la Balze, F. A., Mancini, R. E., Bur, G. E., and Irazu, J. (1954). Morphologic and histochemical changes produced by estrogens on adult human testes.Fertil. Steril. 5: 421–436.
Dörner, G., Rohde, W., Siedel, K., Haas, W., and Schott, G. (1976). On the evocability of a positive oestrogen feedback action on LH secretion in transsexual men and women.Endokrinologie 67: 20–25.
Fotherby, K. (1976). Pharmacology of natural and synthetic estrogens. In Campbell, S. (ed.),The Management of the Menopause and Post-Menopausal Years University Park Press, Baltimore, pp. 87–95.
Frick, J., Bartsch, G., and Marberger, H. (1976). Steroidal compounds (injectable and implants) affecting spermatogenesis in men.J. Reprod. Fertil. 24 (Suppl): 35–47.
Hamburger, C. (1969). Endocrine treatment of male and female transsexualism. In Green, R., and Money, J. (eds.),Transsexualism and Sex Reassignment. Johns Hopkins University Press, Baltimore, pp. 291–307.
Hamilton, W., and Chapman, P. H. (1977). Biochemical determinants in gender identity.Paediat. Paedol. 5: 69–81.
Heller, C. G., Moore, D. J., Paulsen, C. A., Nelson, W. O., and Laidlaw, W. M. (1959). Effects of progesterone and synthetic progestins on the reproductive physiology of normal men.Fed. Proc. 18: 1057–1065.
Johanson, A. J., Guyda, H., Light, C., Migeon, C. J., and Blizzard, R. M. (1969). Serum luteinizing hormone by radioimmunoassay in normal children.J. Pediat. 74: 416–424.
Jones, J. R., and Samimy, J. (1973). Plasma testosterone levels and female transsexualism.Arch. Sex. Behav. 2: 251–256.
Kupperman, H. S., Blatt, M. H. G., Wiesbader, H., and Filler, W. (1953). Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices.J. Clin. Endocrinol. Metab. 13: 688–703.
Lindner, H. R., Perel, E., Friedlander, A., and Zeitlin, A. (1972). Specificity of antibodies to ovarian hormones in relation to the site of attachment of the steroid hapten to the peptide carrier.Steroids 19: 357–375.
Meyer-Bahlburg, H. F. L. (1977). Sex hormones and male homosexuality in comparative perspective.Arch. Sex. Behav. 6: 297–325.
Meyer-Bahlburg, H. F. L. (1979). Sex hormones and female homosexuality: A critical examination.Arch. Sex. Behav. 8: 101–119.
Migeon, C. (1969). Therapy for the control of postcastration symptoms. In Green, R., and Money, J. (eds.),Transsexualism and Sex Reassignment Johns Hopkins University Press, Baltimore, pp. 353–354.
Migeon, C. J., Rivarola, M. A., and Forest, M. G. (1968). Studies of androgens in transsexual subjects: Effects of estrogen therapy.Johns Hopkins Med. J. 123: 128–133.
Money, J., and Walker, P. (1977). Counseling the transsexual. In Money, J., and Musaph, H. (eds.),Handbook of Sexology Excerpta Medica, Amsterdam, pp. 1289–1301.
Payer, A. F., Meyer, W. J., and Walker, P. A. (1979). The ultrastructural response of human Leydig cells to exogenous estrogens.Andrologia 11: 423–436.
Raiti, S., Johanson, A., Light, C., Migeon, C. J., and Blizzard, R. M. (1969). Measurement of immunologically reactive follicle stimulating hormone in serum of normal male children and adults.Metabolism 18: 234–240.
Schonfeld, W. A. (1943). Primary and secondary sexual characteristics: Study of their development in males from birth through maturity, with biometric study of penis and testes.Amer. J. Dis. Child. 65: 535–549.
Sípová, I., and Stárka, L. (1977). Plasma testosterone values in transsexual women.Arch. Sex. Behav. 6: 477–481.
Stárka, L., Sípova, I., and Hynie, J. (1975). Plasma testosterone in male transsexuals and homosexuals.J. Sex. Res. 11: 132–138.
Zachmann, M., Prader, A., Kind, H. P., Häfliger, H., and Budliger, H. (1974). Testicular volume during adolescence: Cross-sectional and longitudinal studies.Helv. Paediat. Acta 29: 61–72.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meyer, W.J., Finkelstein, J.W., Stuart, C.A. et al. Physical and hormonal evaluation of transsexual patients during hormonal therapy. Arch Sex Behav 10, 347–356 (1981). https://doi.org/10.1007/BF01565538
Issue Date:
DOI: https://doi.org/10.1007/BF01565538